Hospital

The phase 2 AXIOMATIC trials assessing milvexian met its primary endpoints, with researchers anticipating a phase 3 trial to come within the year.

An overview of the legal and business tools available to community, specialty, hospital, and health-system pharmacies in seeking to maintain payer network access and combat abusive practices.

Bill Schimmel, CEO and executive director of the Pharmacy Technician Certification Board (PTCB), discusses how pharmacy technicians can face burnout and advocate for themselves.

Georgia State University analysis supports new strategy for creating these vaccines, investigators contend.

Though there is no well-defined therapeutic approach to the treatment of Arndt-Gottron syndrome, intravenous immunoglobulins have been documented as a well-tolerated treatment in some cases.

Zynrelef is indicated in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.

The FDA approval makes olipudase alfa the first approved drug to target the physiological symptoms of the disease.

Lawrence H. Summers, former US Secretary of the Treasury, explains that he is optimistic regarding pharmacy’s increasing role in fighting future pandemics.

Vertical and horizontal consolidation has had a significant impact on retail, specialty, and health-system pharmacies.

With these bivalent vaccine authorizations, the monovalent mRNA COVID-19 vaccines are still not authorized as booster doses for individuals 12 years of age and older.

The benefits of taking a daily statin may improve as a patient grows older.

Desmond Hunt, PhD, senior principal scientist at US Pharmacopeia (USP), discusses the standards and resources that USP has recently published or is looking at now on the subject of pharmacy in transit.

Data have shown there is a rising need for mental health and substance use disorder services, yet there is a shortage of psychiatrists in the country that is estimated to worsen by 2024.

Investigational targeted B-cell therapy demonstrates superior efficacy compared with teriflunomide, a commonly prescribed treatment for MS.

Ozanimod (Zeposia) is indicated for the treatment of multiple sclerosis and moderately to severely active ulcerative colitis in adults.

Atezolizumab meets its primary endpoint of overall survival for patients with resected non-small cell lung cancer across most subgroups.

Device provides tailored relief to multiple pain areas and adds more treatment options for evolving conditions.

Tranexamic acid indicated for patients with hemophilia for short-term use to reduce or prevent hemorrhage and decrease the need for replacement therapy during and following tooth extraction.

New research suggests that icosapent ethyl can significantly decrease cardiovascular risk among former or current smokers with other cardiovascular risk factors.

New research indicates that COVID-19 vaccinations did not increase the risks of preterm births or gestational issues for pregnant women, despite prior conflicting evidence.

Analysis shows that myocarditis was the most commonly diagnosed condition associated with pediatric post-acute sequelae of SARS-CoV-2.

Meropenem IV is an antibacterial medication indicated for the treatment of complicated stomach and skin structure infections.

A panel at the National Association of Chain Drug Stores Total Store Expo discusses the importance of expanding parental leave policies for new parents as well as mentorship for women pursuing leadership positions.

Following the seemingly endless disruptions to the country’s supply chain over the past 2-year period, signs are showing more pain before things get better.

Pemigatinib is the first targeted therapy to gain FDA approval for the treatment of adult patients with relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement.

Yoona Kim, PharmD, PhD, co-founder and CEO of Arine, discusses some of the key takeaways from the launch of Mark Cuban's pharmacy Mark Cuban Cost Plus Drug Co.

Risk factors associated with declining health-related quality of life for adult survivors of childhood cancer, such as physical inactivity and chronic health conditions, should be targets of surveillance and intervention.

Canakinumab did not meet the primary endpoint of disease-free survival in adult patients with stages II-IIIA and IIIB completely resected non-small cell lung cancer.

In a recent survey, researchers identified rising costs, socioeconomic inequity, and drug trends as major concerns for large employers.

Analysis is based on previously reported data collected in March and April 2022, with the FDA granting emergency use authorization for individuals aged 6 months to 4 years on June 17.